{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:51:34Z","timestamp":1790059894157,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11940-010-0103-8","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T15:33:53Z","timestamp":1290440033000},"page":"71-78","source":"Crossref","is-referenced-by-count":28,"title":["Fisher Syndrome"],"prefix":"10.1007","volume":"13","author":[{"given":"Masahiro","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"103_CR1","first-page":"601","volume":"39","author":"J Collier","year":"1932","unstructured":"Collier J: Peripheral neuritis. Edinburgh Med J 1932, 39:601\u2013618.","journal-title":"Edinburgh Med J"},{"key":"103_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M Fisher","year":"1956","unstructured":"Fisher M: An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956, 255:57\u201365.","journal-title":"N Engl J Med"},{"key":"103_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","volume":"31","author":"A Chiba","year":"1992","unstructured":"Chiba A, Kusunoki S, Shimizu T, Kanazawa I: Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992, 31:677\u2013679.","journal-title":"Ann Neurol"},{"key":"103_CR4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","volume":"56","author":"M Mori","year":"2001","unstructured":"Mori M, Kuwabara S, Fukutake T, et al.: Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001, 56:1104\u20131106.","journal-title":"Neurology"},{"key":"103_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.34.7.953","volume":"34","author":"B Sauron","year":"1984","unstructured":"Sauron B, Bouche P, Cathala HP, et al.: Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology 1984, 34:953\u2013956.","journal-title":"Neurology"},{"key":"103_CR6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jnnp.63.4.494","volume":"63","author":"RK Lyu","year":"1997","unstructured":"Lyu RK, Tang LM, Cheng SY, et al.: Guillain-Barr\u00e9 syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997, 63:494\u2013500.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000008201","volume":"44","author":"CL Yuan","year":"2000","unstructured":"Yuan CL, Wang YJ, Tsai CP: Miller fisher syndrome: a hospital-based retrospective study. Eur Neurol 2000, 44:79\u201385.","journal-title":"Eur Neurol"},{"key":"103_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000226599","volume":"62","author":"OD San-Juan","year":"2009","unstructured":"San-Juan OD, Martinez-Herrera JF, Garcia JM, et al.: Miller fisher syndrome: 10 years\u2019 experience in a third-level center. Eur Neurol 2009, 62:149\u2013154.","journal-title":"Eur Neurol"},{"key":"103_CR9","first-page":"57","volume":"12","author":"P Berlit","year":"1992","unstructured":"Berlit P, Rakicky J: The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992, 12:57\u201363.","journal-title":"J Clin Neuroophthalmol"},{"key":"103_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","volume":"80","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, van Koningsveld R, Ruts L, et al.: Recurrent Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 2009, 80:56\u201359.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR11","first-page":"106","volume-title":"Guillain-Barr\u00e9 Syndrome","author":"AH Ropper","year":"1991","unstructured":"Ropper AH, Wijdicks EFM, Truax BT: Guillain-Barr\u00e9 Syndrome. Philadelphia: FA Davis; 1991:106\u2013121."},{"key":"103_CR12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"JH Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RAC: Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome. N Eng J Med 1995, 333:1374\u20131379.","journal-title":"N Eng J Med"},{"key":"103_CR13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jnnp.65.2.218","volume":"65","author":"Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology","year":"1998","unstructured":"Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology: Guillain-Barr\u00e9 syndrome variants in Emilia-Romagna, Italy, 1992\u20133: incidence, clinical features, and prognosis. J Neurol Neurosurg Psychiatry 1998, 65:218\u2013224.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/jnnp.2008.154351","volume":"80","author":"K Funakoshi","year":"2009","unstructured":"Funakoshi K, Kuwabara S, Odaka M, et al.: Clinical predictors of mechanical ventilation in Fisher\/Guillain-Barr\u00e9 overlap syndrome. J Neurol Neurosurg Psychiatry 2009, 80:60\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR15","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/awg233","volume":"126","author":"M Odaka","year":"2003","unstructured":"Odaka M, Yuki N, Yamada M, et al.: Bickerstaff\u2019s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barr\u00e9 syndrome. Brain 2003, 126:2279\u20132290.","journal-title":"Brain"},{"key":"103_CR16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/WNL.43.2.414","volume":"43","author":"N Yuki","year":"1993","unstructured":"Yuki N, Sato S, Tsuji S, et al.: Frequent presence of anti-GQ1b antibody in Fisher\u2019s syndrome. Neurology 1993, 43:414\u2013417.","journal-title":"Neurology"},{"key":"103_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0161-6420(00)00420-6","volume":"108","author":"N Yuki","year":"2001","unstructured":"Yuki N, Odaka M, Hirata K: Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001, 108:196\u2013200.","journal-title":"Ophthalmology"},{"key":"103_CR18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.50.1.307","volume":"50","author":"AJ Radzwill","year":"1998","unstructured":"Radzwill AJ, Steck AJ, Borruat FX, Bogousslavsky J: Isolated internal ophthalmoplegia associated with IgG anti-GQ1b antibody. Neurology 1998, 50:307.","journal-title":"Neurology"},{"key":"103_CR19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp.67.5.668","volume":"67","author":"M Mori","year":"1999","unstructured":"Mori M, Kuwabara S, Koga M, et al.: IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiatry 1999, 67:668\u2013670.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1212\/WNL.54.9.1851","volume":"54","author":"N Yuki","year":"2000","unstructured":"Yuki N, Susuki K, Hirata K: Ataxic Guillain-Barr\u00e9 syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 2000, 54:1851\u20131853.","journal-title":"Neurology"},{"key":"103_CR21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp.61.6.649","volume":"61","author":"CP O\u2019Leary","year":"1996","unstructured":"O\u2019Leary CP, Veitch J, Durward WF, et al.: Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996, 61:649\u2013651.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ana.410360517","volume":"36","author":"N Yuki","year":"1994","unstructured":"Yuki N, Taki T, Takahashi M, et al.: Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher\u2019s syndrome. Ann Neurol 1994, 36:791\u2013793.","journal-title":"Ann Neurol"},{"key":"103_CR23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.57.4.686","volume":"57","author":"M Koga","year":"2001","unstructured":"Koga M, Yuki N, Tai T, Hirata K: Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 2001, 57:686\u2013691.","journal-title":"Neurology"},{"key":"103_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/bi062001v","volume":"46","author":"RS Houliston","year":"2007","unstructured":"Houliston RS, Yuki N, Hirama T, et al.: Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barr\u00e9 and Fisher syndromes. Biochemistry 2007, 46:36\u201344.","journal-title":"Biochemistry"},{"key":"103_CR25","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1021\/bi700685s","volume":"46","author":"RS Houliston","year":"2007","unstructured":"Houliston RS, Koga M, Li J, et al.: A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 2007, 46:8164\u20138171.","journal-title":"Biochemistry"},{"key":"103_CR26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1212\/WNL.47.5.1317","volume":"47","author":"AJ Kornberg","year":"1996","unstructured":"Kornberg AJ, Pestronk A, Blume GM, et al.: Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996, 47:1317\u20131320.","journal-title":"Neurology"},{"issue":"10","key":"103_CR27","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1468-1331.2010.02993.x","volume":"17","author":"E T\u00fcz\u00fcn","year":"2010","unstructured":"T\u00fcz\u00fcn E, K\u00fcrt\u00fcnc\u00fc M, Lang B, et al.: Bickerstaff\u2019s encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies. Eur J Neurol 2010, 17(10):1304\u20131307.","journal-title":"Eur J Neurol"},{"key":"103_CR28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-008-0775-0","volume":"255","author":"M Ito","year":"2008","unstructured":"Ito M, Kuwabara S, Odaka M, et al.: Bickerstaff\u2019s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 2008, 255:674\u2013682.","journal-title":"J Neurol"},{"key":"103_CR29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/1531-8249(199904)45:4<533::AID-ANA19>3.0.CO;2-H","volume":"45","author":"S Kuwabara","year":"1999","unstructured":"Kuwabara S, Asahina M, Nakajima M, et al.: Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol 1999, 45:533\u2013536.","journal-title":"Ann Neurol"},{"key":"103_CR30","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","volume":"43","author":"A Chiba","year":"1993","unstructured":"Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I: Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies. Neurology 1993, 43:1911\u20131917.","journal-title":"Neurology"},{"key":"103_CR31","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.08-3333","volume":"50","author":"JX Liu","year":"2009","unstructured":"Liu JX, Willison HJ, Pedrosa-Domell\u00f6f F: Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 2009, 50:3226\u20133232.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"103_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.10.008","volume":"288","author":"YL Lo","year":"2010","unstructured":"Lo YL, Fook-Chong S, Chan LL, et al.: Electrophysiological evidence of cerebellar fiber system involvement in the Miller Fisher syndrome. J Neurol Sci 2010, 288:49\u201353.","journal-title":"J Neurol Sci"},{"key":"103_CR33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jnnp.2008.154765","volume":"80","author":"YK Kim","year":"2009","unstructured":"Kim YK, Kim JS, Jeong SH, et al.: Cerebral glucose metabolism in Fisher syndrome. J Neurol Neurosurg Psychiatry 2009, 80:512\u2013517.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"103_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mus.10246","volume":"26","author":"K Ogawara","year":"2002","unstructured":"Ogawara K, Kuwabara S, Yuki N: Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve 2002, 26:845\u2013849.","journal-title":"Muscle Nerve"},{"key":"103_CR35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(94)92694-8","volume":"343","author":"M Roberts","year":"1994","unstructured":"Roberts M, Willison H, Vincent A, Newsom-Davis J: Serum factor in Miller-Fisher variant of Guillain-Barr\u00e9 syndrome and neurotransmitter release. Lancet 1994, 343:454\u2013455.","journal-title":"Lancet"},{"key":"103_CR36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1529-8027.2008.00181.x","volume":"13","author":"SK Halstead","year":"2008","unstructured":"Halstead SK, Humphreys PD, Zitman FM, et al.: C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J Peripher Nerv Syst 2008, 13:228\u2013235.","journal-title":"J Peripher Nerv Syst"},{"key":"103_CR37","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","volume":"131","author":"SK Halstead","year":"2008","unstructured":"Halstead SK, Zitman FM, Humphreys PD, et al.: Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 2008, 131:1197\u20131208.","journal-title":"Brain"},{"key":"103_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","volume":"223","author":"K Kaida","year":"2010","unstructured":"Kaida K, Kusunoki S: Antibodies to gangliosides and ganglioside complexes in Guillain-Barr\u00e9 syndrome and Fisher syndrome: mini-review. J Neuroimmunol 2010, 223:5\u201312.","journal-title":"J Neuroimmunol"},{"key":"103_CR39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0387-7604(93)90071-F","volume":"15","author":"Y Arakawa","year":"1993","unstructured":"Arakawa Y, Yoshimura M, Kobayashi S, et al.: The use of intravenous immunoglobulin in Miller Fisher syndrome. Brain Dev 1993, 15:231\u2013233.","journal-title":"Brain Dev"},{"key":"103_CR40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00868348","volume":"241","author":"U Zifko","year":"1994","unstructured":"Zifko U, Drlicek M, Senautka G, Grisold W: High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 1994, 241:178\u2013179.","journal-title":"J Neurol"},{"key":"103_CR41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.wnl.0000258673.31824.61","volume":"68","author":"M Mori","year":"2007","unstructured":"Mori M, Kuwabara S, Fukutake T, Hattori T: Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 2007, 68:1144\u20131146.","journal-title":"Neurology"},{"key":"103_CR42","doi-asserted-by":"crossref","unstructured":"Overell JR, Hsieh ST, Odaka M, et al.: Treatment for Fisher syndrome, Bickerstaff\u2019s brainstem encephalitis and related disorders. Cochrane Database Syst Rev 2007, (1):CD004761.","DOI":"10.1002\/14651858.CD004761.pub2"},{"key":"103_CR43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mus.21433","volume":"40","author":"PD Donofrio","year":"2009","unstructured":"Donofrio PD, Berger A, Brannagan 3rd TH, et al.: Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Muscle Nerve 2009, 40:890\u2013900.","journal-title":"Muscle Nerve"},{"key":"103_CR44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/bmj.282.6266.778","volume":"282","author":"R Littlewood","year":"1981","unstructured":"Littlewood R, Bajada S: Successful plasmapheresis in the Miller-Fisher syndrome. Br Med J (Clin Res Ed) 1981, 282:778.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"103_CR45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9394(99)80160-3","volume":"125","author":"K Ohtsuka","year":"1998","unstructured":"Ohtsuka K, Nakamura Y, Tagawa Y, Yuki N: Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody. Am J Ophthalmol 1998, 125:403\u2013406.","journal-title":"Am J Ophthalmol"},{"key":"103_CR46","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jnnp.72.5.680","volume":"72","author":"M Mori","year":"2002","unstructured":"Mori M, Kuwabara S, Fukutake T, Hattori T: Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurol Neurosurg Psychiatry 2002, 72:680.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0103-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0103-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:56Z","timestamp":1559437016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0103-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}